Britt Mellström

Consejo Superior de Investigaciones Científicas — Spain

Neuroscience · Life Sciences

45h-index5.9kcitations113works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(22), Ion channel regulation and function(15), Pharmacogenetics and Drug Metabolism(12), Neuropeptides and Animal Physiology(11), RNA Research and Splicing(10)

Publications113 total

Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice
International Journal of Molecular Sciences·2023· 4 citedOpen Access
Repaglinide Induces ATF6 Processing and Neuroprotection in Transgenic SOD1G93A Mice
Preprints.org·2023· 1 citedOpen Access
Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington’s disease treatment
Scientific Reports·2019· 19 citedOpen Access
Fine-tuning DREAM signaling using chemical tools for neurodegenerative disease treatment
2019
Inhibition of the Neuronal Calcium Sensor DREAM Modulates Presenilin-2 Endoproteolysis
Frontiers in Molecular Neuroscience·2018· 13 citedOpen Access
Inhibition of DREAM-ATF6 interaction delays onset of cognition deficit in a mouse model of Huntington’s disease
Molecular Brain·2018· 23 citedOpen Access
Fos/Jun in Brain Function
2017
Tailoring chemical tools for modulating the Kv4.3/KChIP3 interaction
2017
Specific cytoarchitectureal changes in hippocampal subareas in daDREAM mice
Molecular Brain·2016· 19 citedOpen Access
Transcriptional repressor DREAM regulates trigeminal noxious perception
Journal of Neurochemistry·2016· 16 citedOpen Access
Activating transcription factor 6 derepression mediates neuroprotection in Huntington disease
Journal of Clinical Investigation·2016· 66 citedOpen Access
Novel small molecules targeting the KChIP-3/Kv4.3 interaction
DIGITAL.CSIC (Spanish National Research Council (CSIC))·2016
Dream-modulators for dreaming of novel drugs for neurodegenerative diseases
DIGITAL.CSIC (Spanish National Research Council (CSIC))·2015
Kcnip1 a Ca2+-dependent transcriptional repressor regulates the size of the neural plate in Xenopus
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research·2014· 14 cited
Methods for the prognosus and suagnosis of neurodegenerative diseases
DIGITAL.CSIC (Spanish National Research Council (CSIC))·2014Open Access
Activation of DREAM (Downstream Regulatory Element Antagonistic Modulator), a Calcium-Binding Protein, Reduces L-DOPA-Induced Dyskinesias in Mice
Biological Psychiatry·2014· 57 citedOpen Access
DREAM Controls the On/Off Switch of Specific Activity-Dependent Transcription Pathways
Molecular and Cellular Biology·2013· 39 citedOpen Access
DREAM Mediated Regulation of GCM1 in the Human Placental Trophoblast
PLoS ONE·2013· 31 citedOpen Access
Ca2+-dependent Transcriptional Control of Ca2+ Homeostasis
Journal of Biological Chemistry·2012· 69 citedOpen Access
Ca2+-activated Nucleotidase 1, a Novel Target Gene for the Transcriptional Repressor DREAM (Downstream Regulatory Element Antagonist Modulator), Is Involved in Protein Folding and Degradation
Journal of Biological Chemistry·2012· 27 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

José R. Naranjo(36), Folke Sjöqvist(8), Leif Bertilsson(6), Magali Savignac(6), Paolo Sassone‐Corsi(5), Ángel Manuel Carrión(4), Wolfgang Link(4), Juliette Säwe(4), Fran Ledo(3), Matilde Achaval(3), Rosa Gómez‐Villafuertes(3), Paz González(3), Nicholas S. Foulkes(2), Juan Lerma(2), Ángel Santos(2), Lil Träskman(2), Miguel Lafarga(2), José J. Lucas(2), Begoña Torres(2), Belén Pintado(2)